Funding Rounds
Core Biogenesis

Core Biogenesis Series A (2022, $11M)

Core Biogenesis

Biotechnology platform developing advanced recombinant protein production technologies.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $11.01M

Raised Date: 2022-01-01

Investors